Search News
| 4.10 Delayed Data As of Apr 25 |  0.00 / 0.00%Today’s Change | 3.20 Today|||52-Week Range 9.41 | -40.56% Year-to-Date |
| Previous close | 4.10 |
| Today’s open | 3.95 |
| Day’s range | 3.95 - 4.15 |
| Volume | 58 |
| Average volume (3 months) | 15,216 |
| Market cap | $56.3M |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +40.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.60 |
| Today’s change | Today’s % change | |
|---|---|---|
| CHMAChiasma Inc | 0.00 | 0.00% |
| XENEXenon Pharmaceutical... | 0.00 | 0.00% |
| APDNApplied DNA Sciences... | -0.01 | -0.37% |
| EGLTEgalet Corp | +0.01 | +0.98% |
| Next reporting date | May 10, 2018 |
| EPS forecast (this quarter) | -$0.56 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$21.3M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Natasha Giordano |
Chief Financial Officer Rita M. O'Connor |
Corporate headquarters Houston, Texas |
